Dyserythropoiesis in 105 patients with visceral leishmaniasis

Anwar Sheikha1

  • 1Department of Hematology, College of Medicine, King Khalid University, Abha, Saudi Arabia. anwarsheikha@msn.com

Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology
|February 9, 2005
PubMed

Insights

Diagnosing visceral leishmaniasis in bone marrow requires careful examination. Frank nuclear dyserythropoiesis may indicate low parasite levels, necessitating extended microscopy for Leishman-Donovan bodies.

Area of Science:

  • Hematology
  • Parasitology
  • Infectious Diseases

Background:

  • Visceral leishmaniasis is a serious parasitic disease with high global incidence, primarily affecting malnourished children.
  • The disease is increasingly diagnosed in immunocompromised individuals and travelers.
  • Bone marrow examination is crucial for diagnosing parasitic infections in endemic regions.

Purpose of the Study:

  • To investigate the relationship between nuclear dyserythropoiesis and Leishman-Donovan bodies in bone marrow samples.
  • To highlight the diagnostic challenges in visceral leishmaniasis, particularly when parasite load is low.

Main Methods:

  • Retrospective analysis of 442 bone marrow examination requests over 18 years.
  • Diagnosis of visceral leishmaniasis based on the presence of Leishman-Donovan bodies.
  • Evaluation of nuclear dyserythropoiesis in bone marrow smears.

Main Results:

  • 105 cases of visceral leishmaniasis were diagnosed.
  • Prominent nuclear dyserythropoiesis was observed in 17 patients, 14 with a frank type.
  • Most cases with frank nuclear dyserythropoiesis showed low marrow parasitemia, inversely correlated with dyserythropoiesis severity.

Conclusions:

  • Extended microscopy is recommended for detecting Leishman-Donovan bodies in suspected visceral leishmaniasis with prominent frank nuclear dyserythropoiesis.
  • Frank nuclear dyserythropoiesis may be an indicator of low parasite burden.
  • A common chemokine or cytokine might influence both nuclear dyserythropoiesis and marrow parasitemia.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...